Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023).    No concomitant medication was reported.  Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 1 out of 50 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-735334, US-MODERNATX, INC.-MOD-2023-735345, US-MODERNATX, INC.-MOD-2023-735346, US-MODERNATX, INC.-MOD-2023-735347, US-MODERNATX, INC.-MOD-2023-735350, US-MODERNATX, INC.-MOD-2023-735351, US-MODERNATX, INC.-MOD-2023-735363, US-MODERNATX, INC.-MOD-2023-735367, US-MODERNATX, INC.-MOD-2023-735368, US-MODERNATX, INC.-MOD-2023-735369, US-MODERNATX, INC.-MOD-2023-735371, US-MODERNATX, INC.-MOD-2023-735372, US-MODERNATX, INC.-MOD-2023-735370, US-MODERNATX, INC.-MOD-2023-735373, US-MODERNATX, INC.-MOD-2023-735375, US-MODERNATX, INC.-MOD-2023-735378, US-MODERNATX, INC.-MOD-2023-735379, US-MODERNATX, INC.-MOD-2023-735384, US-MODERNATX, INC.-MOD-2023-735380, US-MODERNATX, INC.-MOD-2023-735382, US-MODERNATX, INC.-MOD-2023-735386, US-MODERNATX, INC.-MOD-2023-735387, US-MODERNATX, INC.-MOD-2023-735390, US-MODERNATX, INC.-MOD-2023-735388, US-MODERNATX, INC.-MOD-2023-735389, US-MODERNATX, INC.-MOD-2023-735396, US-MODERNATX, INC.-MOD-2023-735395, US-MODERNATX, INC.-MOD-2023-735398, US-MODERNATX, INC.-MOD-2023-735397, US-MODERNATX, INC.-MOD-2023-735399, US-MODERNATX, INC.-MOD-2023-735400, US-MODERNATX, INC.-MOD-2023-735401, US-MODERNATX, INC.-MOD-2023-735402, US-MODERNATX, INC.-MOD-2023-735403, US-MODERNATX, INC.-MOD-2023-735404, US-MODERNATX, INC.-MOD-2023-735407, US-MODERNATX, INC.-MOD-2023-735405, US-MODERNATX, INC.-MOD-2023-735410, US-MODERNATX, INC.-MOD-2023-735415, US-MODERNATX, INC.-MOD-2023-735418, US-MODERNATX, INC.-MOD-2023-735430, US-MODERNATX, INC.-MOD-2023-735435, US-MODERNATX, INC.-MOD-2023-735443, US-MODERNATX, INC.-MOD-2023-735452, US-MODERNATX, INC.-MOD-2023-735340, US-MODERNATX, INC.-MOD-2023-735349, US-MODERNATX, INC.-MOD-2023-735348 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735334:Patient 2 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735347:Patient 7out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735350:Patient 10  out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735346:Patient 6  out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735345:Patient 5 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735351:Patient 11 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735403:Patient 30  out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735404:Patient 37 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735395:Patient 28 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735380:Patient 26 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735399:Patient 21 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735379:Patient 16 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735405:Patient 47 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735389:Patient 44 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735397:Patient 45 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735415:Patient 49 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735371:Patient 14 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735430:Patient 38 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735386:Patient 18 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735363:Patient 22 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735369:Patient 13 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735372:Patient 33 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735375:Patient 15 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735382:Patient 43 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735390:Patient 19 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735418:Patient 50 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735368:Patient 32 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735378:Patient 25 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735410:Patient 48 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735435:Patient 39 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735384:Patient 17 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735452:Patient 41 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735443:Patient 40  out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735396:Patient 20 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735370:Patient 42 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735367:Patient 12 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735407:Patient 31 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735402:Patient 46 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735401:Patient 36 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735400:Patient 29 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735398:Patient 35 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735388:Patient 34 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735373:Patient 24 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735387:Patient 27 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735340:Patient 03 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735349:Patient 09 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735348:Patient 08 out of 50 (Lot AS7143C was administered on 5Jun2023)